685 related articles for article (PubMed ID: 22798562)
1. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
2. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
3. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
[TBL] [Abstract][Full Text] [Related]
4. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
[TBL] [Abstract][Full Text] [Related]
5. Intracellular calcium current disorder and disease phenotype in
Chen P; Xiao Y; Wang Y; Zheng Z; Chen L; Yang X; Li J; Wu W; Zhang S
Theranostics; 2020; 10(24):11215-11229. PubMed ID: 33042279
[TBL] [Abstract][Full Text] [Related]
6. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
[TBL] [Abstract][Full Text] [Related]
7. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice.
Kirchhof P; Fabritz L; Zwiener M; Witt H; Schäfers M; Zellerhoff S; Paul M; Athai T; Hiller KH; Baba HA; Breithardt G; Ruiz P; Wichter T; Levkau B
Circulation; 2006 Oct; 114(17):1799-806. PubMed ID: 17030684
[TBL] [Abstract][Full Text] [Related]
8. Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.
Hariharan V; Asimaki A; Michaelson JE; Plovie E; MacRae CA; Saffitz JE; Huang H
Cardiovasc Res; 2014 Nov; 104(2):280-9. PubMed ID: 25253076
[TBL] [Abstract][Full Text] [Related]
9. Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis.
Antoniades L; Tsatsopoulou A; Anastasakis A; Syrris P; Asimaki A; Panagiotakos D; Zambartas C; Stefanadis C; McKenna WJ; Protonotarios N
Eur Heart J; 2006 Sep; 27(18):2208-16. PubMed ID: 16893920
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the molecular phenotype of two arrhythmogenic right ventricular cardiomyopathy (ARVC)-related plakophilin-2 (PKP2) mutations.
Joshi-Mukherjee R; Coombs W; Musa H; Oxford E; Taffet S; Delmar M
Heart Rhythm; 2008 Dec; 5(12):1715-23. PubMed ID: 19084810
[TBL] [Abstract][Full Text] [Related]
11. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy.
Syrris P; Ward D; Asimaki A; Sen-Chowdhry S; Ebrahim HY; Evans A; Hitomi N; Norman M; Pantazis A; Shaw AL; Elliott PM; McKenna WJ
Circulation; 2006 Jan; 113(3):356-64. PubMed ID: 16415378
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the Role of Wnt and Rho Signaling Pathway in iPSC-Derived ARVC Cardiomyocytes by In Silico Mathematical Modeling.
Parrotta EI; Procopio A; Scalise S; Esposito C; Nicoletta G; Santamaria G; De Angelis MT; Dorn T; Moretti A; Laugwitz KL; Montefusco F; Cosentino C; Cuda G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670616
[TBL] [Abstract][Full Text] [Related]
13. Molecular insights into arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 missense mutations.
Kirchner F; Schuetz A; Boldt LH; Martens K; Dittmar G; Haverkamp W; Thierfelder L; Heinemann U; Gerull B
Circ Cardiovasc Genet; 2012 Aug; 5(4):400-11. PubMed ID: 22781308
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis and evaluation of the cardiac localization of TMEM43 in arrhythmogenic right ventricular cardiomyopathy.
Christensen AH; Andersen CB; Tybjaerg-Hansen A; Haunso S; Svendsen JH
Clin Genet; 2011 Sep; 80(3):256-64. PubMed ID: 21214875
[TBL] [Abstract][Full Text] [Related]
15. Arrhythmogenic right ventricular cardiomyopathy: moving toward mechanism.
MacRae CA; Birchmeier W; Thierfelder L
J Clin Invest; 2006 Jul; 116(7):1825-8. PubMed ID: 16823481
[TBL] [Abstract][Full Text] [Related]
16. Loss of Nuclear Envelope Integrity and Increased Oxidant Production Cause DNA Damage in Adult Hearts Deficient in PKP2: A Molecular Substrate of ARVC.
Pérez-Hernández M; van Opbergen CJM; Bagwan N; Vissing CR; Marrón-Liñares GM; Zhang M; Torres Vega E; Sorrentino A; Drici L; Sulek K; Zhai R; Hansen FB; Christensen AH; Boesgaard S; Gustafsson F; Rossing K; Small EM; Davies MJ; Rothenberg E; Sato PY; Cerrone M; Jensen THL; Qvortrup K; Bundgaard H; Delmar M; Lundby A
Circulation; 2022 Sep; 146(11):851-867. PubMed ID: 35959657
[TBL] [Abstract][Full Text] [Related]
17. Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene.
Khudiakov A; Kostina D; Zlotina A; Yany N; Sergushichev A; Pervunina T; Tomilin A; Kostareva A; Malashicheva A
Stem Cell Res; 2017 Oct; 24():85-88. PubMed ID: 29034900
[TBL] [Abstract][Full Text] [Related]
18. Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations.
Fidler LM; Wilson GJ; Liu F; Cui X; Scherer SW; Taylor GP; Hamilton RM
J Cell Mol Med; 2009 Oct; 13(10):4219-28. PubMed ID: 18662195
[TBL] [Abstract][Full Text] [Related]
19. Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy.
Noorman M; Hakim S; Kessler E; Groeneweg JA; Cox MG; Asimaki A; van Rijen HV; van Stuijvenberg L; Chkourko H; van der Heyden MA; Vos MA; de Jonge N; van der Smagt JJ; Dooijes D; Vink A; de Weger RA; Varro A; de Bakker JM; Saffitz JE; Hund TJ; Mohler PJ; Delmar M; Hauer RN; van Veen TA
Heart Rhythm; 2013 Mar; 10(3):412-9. PubMed ID: 23178689
[TBL] [Abstract][Full Text] [Related]
20. [THE EFFECT OF PLAKOPHILIN-2 GENE MUTATIONS ON ACTIVITY OF THE CANONICAL Wnt SIGNALING PATHWAY].
Khudiakov AA; Kostina DA; Kostareva AA; Tomilin AN; Malashicheva AB
Tsitologiia; 2015; 57(12):868-75. PubMed ID: 26995964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
